Projected 30- day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part D

Pancreatology. 2021 Aug;21(5):1009-1010. doi: 10.1016/j.pan.2021.05.002. Epub 2021 May 11.

¹ The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. Electronic address: [email protected].
² Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
³ The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
⁴ Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
⁵ Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, USA; Vanderbilt Ingram Cancer Center, Nashville, TN, USA.

No abstract available

Keywords: Cost; Exocrine pancreatic insufficiency; Medicare; Pancreatic ductal adenocarcinoma (PDAC); Pancreatic enzymes.

MeSH terms